Ron Bentsur - 19 May 2022 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
Chairman & CEO, Director, 10%+ Owner
Signature
/s/ Ron Bentsur
Issuer symbol
NVCT
Transactions as of
19 May 2022
Net transactions value
+$20,070
Form type
4
Filing time
23 May 2022, 08:32:21 UTC
Previous filing
19 May 2022
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $3,790 +200 +0.01% $18.95 2,961,614 19 May 2022 Direct F1
transaction NVCT Common Stock Purchase $16,280 +1,000 +0.03% $16.28 2,962,614 20 May 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 96,759 shares of restricted stock and 120,000 restricted stock units.